Results 1 to 10 of about 390 (101)

Influence of subretinal drusenoid deposit on retinal sensitivity in age-related macular degeneration [PDF]

open access: yesScientific Reports
This retrospective study aimed to assess the impact of subretinal drusenoid deposit (SDD), also known as reticular pseudodrusen, on retinal sensitivity (RS) in patients with intermediate age-related macular degeneration (iAMD) using microperimetry.
Soo Hyun Lim   +7 more
doaj   +4 more sources

Subretinal Drusenoid Deposit Formation: Insights From Turing Patterns. [PDF]

open access: yesTransl Vis Sci Technol, 2022
The purpose of this study was to demonstrate that the organized formation of subretinal drusenoid deposits (SDDs) may be a Turing pattern.A Java-based computational model of an inferred reaction-diffusion system using paired partial differential equations was used to create topographic images.
Young BK, Shen LL, Del Priore LV.
europepmc   +5 more sources

Subretinal drusenoid deposits: An update

open access: yesTaiwan Journal of Ophthalmology, 2022
A wide spectrum of phenotypic manifestations characterizes age-related macular degeneration (AMD). Drusen is considered the hallmark of AMD and is located underneath the retinal pigment epithelium (RPE). In contrast, subretinal drusenoid deposits (SDDs),
Manuel Monge, Adriana Araya, Lihteh Wu
doaj   +3 more sources

Biometrics, Impact, and Significance of Basal Linear Deposit and Subretinal Drusenoid Deposit in Age-Related Macular Degeneration. [PDF]

open access: yesInvest Ophthalmol Vis Sci, 2021
Basal linear deposit (BLinD) is a thin layer of soft drusen material. To elucidate the biology of extracellular deposits conferring age-related macular degeneration (AMD) progression risk and inform multimodal clinical imaging based on optical coherence tomography (OCT), we examined lipid content and regional prevalence of BLinD, soft drusen, pre-BLinD,
Chen L   +4 more
europepmc   +5 more sources

SUBRETINAL DRUSENOID DEPOSIT IN AGE-RELATED MACULAR DEGENERATION: Histologic Insights Into Initiation, Progression to Atrophy, and Imaging. [PDF]

open access: yesRetina, 2020
Purpose: To clarify the role of subretinal drusenoid deposits (SDD; pseudodrusen) in the progression of age-related macular degeneration through high-resolution histology. Methods: In 33 eyes of 32 donors (early age-related macular degeneration, n = 15; geographic atrophy, n = 9 ...
Chen L   +5 more
europepmc   +4 more sources

Association between Subretinal Drusenoid Deposits and Age-Related Macular Degeneration in Multimodal Retinal Imaging. [PDF]

open access: yesJ Clin Med, 2023
Multimodal retinal imaging enables the detection of subretinal drusenoid deposits (SDD) with significantly greater accuracy compared to fundus photography. The study aimed to analyze a relationship between the presence of SDD, the clinical picture of AMD, and disease progression in a 3 year follow-up.
Krytkowska E   +4 more
europepmc   +3 more sources

Subretinal Drusenoid Deposits in a Patient With HELLP (Hemolysis, Elevated Liver Enzymes, Low Platelet) Syndrome. [PDF]

open access: yesCureus
Subretinal drusenoid deposits (SDD) are findings that can be observed in age-related macular degeneration as well as in ischemic ocular diseases. These deposits are believed to be of prognostic importance, as they have been shown to be associated with choroidal neovascularization.
Durmaz Engin C, Karti O, Kandemir K.
europepmc   +3 more sources

Biologically Guided Optimization of Test Target Location for Rod-mediated Dark Adaptation in Age-related Macular Degeneration

open access: yesOphthalmology Science, 2023
Purpose: We evaluate the impact of test target location in assessing rod-mediated dark adaptation (RMDA) along the transition from normal aging to intermediate age-related macular degeneration (AMD).
Cynthia Owsley, PhD, MSPH   +5 more
doaj   +1 more source

Lysolipids are prominent in subretinal drusenoid deposits, a high-risk phenotype in age-related macular degeneration

open access: yesFrontiers in Ophthalmology, 2023
IntroductionAge related macular degeneration (AMD) causes legal blindness worldwide, with few therapeutic targets in early disease and no treatments for 80% of cases.
David M. G. Anderson   +14 more
doaj   +1 more source

Home - About - Disclaimer - Privacy